| NCT Number | NCT06860516 |
| Lead Sponsor | GentiBio, Inc |
| Conditions | Diabetes Mellitus, Type I |
| Enrollment | 200 participants |
| Start Date | 2025-06-06 |
| Primary Completion | 2027-01-30 (estimated) |
| Study Completion | 2027-03 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-11 |